In line with this, infection with the earlier introduced VVs encoding antibodies that target VEGF and EGFR (GLV-1h44), or VEGF and FAP (GLV-1h446) diminished angiogenesis and tumor cell proliferation in human prostate tumor xenografts. Here, FAP is linked to neoplasm.